For healthcare professionals, life science professionals, and decision makers

About Us Editorial Team Contact Us

© 2025 - 2026

The Life Science Feed. All rights reserved.

A digital publication from Grá & Mawi Media Co.

Allergy
Andrology
Cardiology
Critical Care
Dentistry
Dermatology
Digital Health
Emergency Medicine
Endocrinology
Gastroenterology

View all therapy areas →

•

Acne Vulgaris
Acute Kidney Injury
Acute Respiratory Distress Syndrome
ADHD
Adrenal Gland Diseases
AI in Healthcare
Allergic Rhinitis
Alopecia Areata
Alzheimer Disease
Amyotrophic Lateral Sclerosis

View all disease areas →

•

Case
Guidelines
Innovation
Insights
News
Policy
Practice
Research

Disease Area

Amyotrophic Lateral Sclerosis

Loading articles...

Evidence-based medical news for healthcare professionals.

About Us

About
Advertise With Us
AI Disclaimer
Contact Us
Editorial Policy
Editorial Team
Press & Media

Legal

Accessibility
Cookie Policy
Copyright
Privacy Policy
Terms & Conditions

Therapy Areas

Cardiology
Dermatology
Endocrinology
Gastroenterology
Neurology
Oncology
Psychiatry
Pulmonology
Rare Diseases
Rheumatology

View all therapy areas →

Disease Areas

Health Policy
Solid Tumors
COVID-19
Obesity
Chronic Disease
Type 2 Diabetes
Coronary Artery Disease
Multiple Myeloma
Heart Failure
Leukemia

View all disease areas →

Content on this site is drafted with AI assistance and reviewed and approved by the editorial team before publication. This publication is intended for healthcare professionals, researchers, and life science industry professionals. Content is provided for informational and educational purposes only and does not constitute medical advice.

© 2025–2026 The Life Science Feed. All rights reserved. A digital publication from Grá & Mawi Media Co.

?

0:00 / 0:00

CategoryKeyword

Amyotrophic Lateral Sclerosis
Huntington's Disease Therapy Faces Regulatory Setbacks, Clinical Impact
A novel investigational therapy for Huntington's disease has encountered significant regulatory hurdles, prompting re-evaluation of its clinical development pathway.
Get the full story
10 min read

Congresses

ESC 2026 • Munich, DE

• Aug 28 – 31 ERS 2026 • Barcelona, ES

• Sep 5 – 9 EASD 2026 • Milan, IT

• Sep 28 – Oct 2 UEG Week 2026 • Vienna, AT

• Oct 3 – 7 Joint ACTRIMS-ECTRIMS 2026 • Toronto, CA

• Oct 21 – 23 ESMO 2026 • Madrid, ES

• Oct 23 – 27 AHA 2026 • Chicago, US

• Nov 7 – 9 ACR 2026 • Washington DC, US

• Nov 14 – 19 ASH 2026 • New Orleans, US

• Dec 12 – 15 ACC.27 Together With WCC • Houston, US

• Apr 10 – 12 ESC 2026 • Munich, DE

• Aug 28 – 31 ERS 2026 • Barcelona, ES

• Sep 5 – 9 EASD 2026 • Milan, IT

• Sep 28 – Oct 2 UEG Week 2026 • Vienna, AT

• Oct 3 – 7 Joint ACTRIMS-ECTRIMS 2026 • Toronto, CA

• Oct 21 – 23 ESMO 2026 • Madrid, ES

• Oct 23 – 27 AHA 2026 • Chicago, US

• Nov 7 – 9 ACR 2026 • Washington DC, US

• Nov 14 – 19 ASH 2026 • New Orleans, US

• Dec 12 – 15 ACC.27 Together With WCC • Houston, US

• Apr 10 – 12

TrendingMyelofibrosis Management: Cytopenia Guides Treatment at EHA 2026